ATE194603T1 - Ein verfahren zur herstellung von tetrazolyl- verbindungen - Google Patents

Ein verfahren zur herstellung von tetrazolyl- verbindungen

Info

Publication number
ATE194603T1
ATE194603T1 AT95101055T AT95101055T ATE194603T1 AT E194603 T1 ATE194603 T1 AT E194603T1 AT 95101055 T AT95101055 T AT 95101055T AT 95101055 T AT95101055 T AT 95101055T AT E194603 T1 ATE194603 T1 AT E194603T1
Authority
AT
Austria
Prior art keywords
producing
tetrazolyl compounds
tetrazolyl compound
tetrazolyl
compounds
Prior art date
Application number
AT95101055T
Other languages
English (en)
Inventor
Yasushi Shida
Kokichi Yoshida
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE194603T1 publication Critical patent/ATE194603T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT95101055T 1994-01-28 1995-01-26 Ein verfahren zur herstellung von tetrazolyl- verbindungen ATE194603T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP823394 1994-01-28

Publications (1)

Publication Number Publication Date
ATE194603T1 true ATE194603T1 (de) 2000-07-15

Family

ID=11687442

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95101055T ATE194603T1 (de) 1994-01-28 1995-01-26 Ein verfahren zur herstellung von tetrazolyl- verbindungen

Country Status (9)

Country Link
US (2) US5578733A (de)
EP (1) EP0668272B1 (de)
AT (1) ATE194603T1 (de)
CA (1) CA2141175C (de)
DE (1) DE69517832T2 (de)
DK (1) DK0668272T3 (de)
ES (1) ES2147798T3 (de)
GR (1) GR3034464T3 (de)
PT (1) PT668272E (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE416784T1 (de) 2000-12-01 2008-12-15 Takeda Pharmaceutical Verfahren zur herstellung einer zubereitung mit einer bioaktiven substanz
CA2466659A1 (en) 2001-11-13 2003-05-22 Takeda Chemical Industries, Ltd. Anticancer agents
EP1482896A4 (de) * 2002-03-01 2005-11-23 Merck & Co Inc Aminoalkylphosphonate und verwandte verbindungen als edg-rezeptor-agonisten
WO2004083192A1 (en) * 2003-03-17 2004-09-30 Teva Pharmaceutical Industries Ltd. Polymorphis of valsartan
US7504516B2 (en) 2003-03-27 2009-03-17 Hetero Drugs Limited Crystalline forms of candesartan cilexetil
EP1556363A2 (de) 2003-04-21 2005-07-27 Teva Pharmaceutical Industries Limited Verfahren zur herstellung von valsartan und zwischenprodukte davon
CZ297016B6 (cs) * 2003-08-27 2006-08-16 Zentiva, A.S. Zpusob odstranování trifenylmethanové chránicí skupiny z 1-trityl-5-(4'-subst. aminomethyl-1,1' -bifenyl-2-yl)-1H-tetrazolu a zpusob výroby draselné soli losartanu, irbesartanu a valsartanu s jeho pouzitím
DE602004005488T2 (de) * 2003-10-16 2007-11-29 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung von candesartan cilexetil
WO2005051928A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Process for production of tetrazolyl compounds
US7692023B2 (en) 2004-02-11 2010-04-06 Teva Pharmaceutical Industries Ltd. Candesartan cilexetil polymorphs
US20050250827A1 (en) * 2004-05-05 2005-11-10 Etinger Marina Y Preparation of candesartan cilexetil in high purity
WO2005123720A1 (en) * 2004-06-18 2005-12-29 Ranbaxy Laboratories Limited Fine particles of the angiotensin ii antagonist candesartan cilexetil and process for production thereof
EP1655298A1 (de) * 2004-11-03 2006-05-10 LEK Pharmaceuticals d.d. Krystalline Polymorpheme Formen von Candesartan Cilexetil
WO2006050922A1 (en) * 2004-11-11 2006-05-18 Lek Pharmaceuticals D.D. Process for the synthesis of tetrazoles
CA2590894A1 (en) * 2005-01-14 2006-07-20 Teva Pharmaceutical Industries Ltd. Preparation of crude candesartan cilexetil
CA2599415C (en) * 2005-05-10 2011-07-19 Teva Pharmaceutical Industries Ltd. Stable micronized candesartan cilexetil and methods for preparing thereof
AR053517A1 (es) 2005-06-06 2007-05-09 Medichem Sa Proceso para la preparacion de compuestos de tetrazolilo, uso de los mismos en el tratamiento de enfermedades circulatorias y formulaciones farmaceuticas que los contienen.
EP1816131A1 (de) * 2006-02-06 2007-08-08 KRKA, tovarna zdravil, d.d., Novo mesto Verfahren zur Herstellung von Olmesartan Medoxomil
CA2616466A1 (en) * 2005-07-29 2007-02-15 Krka Process for the preparation of olmesartan medoxomil
SI22127A (sl) 2005-10-07 2007-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo kandesartan cileksetila
CZ299265B6 (cs) * 2005-10-20 2008-05-28 Zentiva, A. S. Zpusob výroby 1-(cyklohexyloxykarbonyloxy)ethyl-2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)bifenyl-4-yl]methyl]benzimidazol-7-karboxylátu (candesartan cilexetilu)
ITTO20060560A1 (it) * 2006-07-27 2008-01-28 S I M S S R L Composti intermedi per la preparazione di antagonisti dell¿angiotensina ii
EP2049510A1 (de) * 2006-07-28 2009-04-22 Krka Tovarna Zdravil, D.D., Novo Mesto Verfahren zur herstellung von candesartandilexetil form i
WO2009007986A1 (en) * 2007-07-11 2009-01-15 Alembic Limited An improved process for the preparation of candesartan cilexetil
AP2011005999A0 (en) 2009-05-20 2011-12-31 Ranbaxy Lab Ltd Process for the preparation of olmesartan medoxomil.
WO2011080684A1 (en) 2009-12-31 2011-07-07 Ranbaxy Laboratories Limited Process for the preparation of candesartan cilexetil
WO2011092666A1 (en) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited An improved process for the preparation of candesartan cilexetil, polymorphic forms of n-trityl candesartan and their uses thereof
KR101251741B1 (ko) 2010-12-16 2013-04-05 동화약품주식회사 칸데사르탄실렉세틸의 개선된 제조방법
CN103396408A (zh) * 2013-08-13 2013-11-20 河南华商药业有限公司 坎地沙坦酯中杂质b的制备方法
CN109627234A (zh) * 2019-01-30 2019-04-16 浙江省食品药品检验研究院 一种坎地沙坦酯晶体及其制备方法
CN109776503A (zh) * 2019-01-30 2019-05-21 浙江省食品药品检验研究院 一种坎地沙坦酯晶体及其制备方法
CN109851612A (zh) * 2019-01-30 2019-06-07 浙江省食品药品检验研究院 一种坎地沙坦酯晶体及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
GB9017480D0 (en) * 1990-08-09 1990-09-26 Ici Plc Chemical process
TW209213B (de) * 1991-08-21 1993-07-11 Yamanouchi Pharma Co Ltd
CA2077419C (en) * 1991-09-10 1998-08-25 Yasushi Honma Imidazopyridine derivatives and process for preparation thereof
DE4132632A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Substituierte imidazolyl-propensaeurederivate
EP0550313A1 (de) * 1991-12-30 1993-07-07 Synthelabo 2-(Tetranol-5-yl)-(1,1'-Biphenyl)derivate, ihre Herstellung und Anwendung als Zwischenverbindungen
DE4212748A1 (de) * 1992-04-16 1993-10-21 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
US5578733A (en) 1996-11-26
DK0668272T3 (da) 2000-09-18
EP0668272B1 (de) 2000-07-12
CA2141175C (en) 2006-12-12
DE69517832D1 (de) 2000-08-17
US5763619A (en) 1998-06-09
CA2141175A1 (en) 1995-07-29
GR3034464T3 (en) 2000-12-29
PT668272E (pt) 2000-10-31
EP0668272A2 (de) 1995-08-23
DE69517832T2 (de) 2000-11-09
EP0668272A3 (de) 1995-08-30
ES2147798T3 (es) 2000-10-01

Similar Documents

Publication Publication Date Title
ATE194603T1 (de) Ein verfahren zur herstellung von tetrazolyl- verbindungen
ATE174903T1 (de) Neues verfahren zur herstellung von 7- (substituierten)-9-((substistuierter
ATE142634T1 (de) Verfahren zur herstellung von alkylpolyglucosiden
DE69119234D1 (de) Verfahren zur herstellung von reiner hydroxyessigsäure
HUT77178A (hu) Szubsztituált 3-amino-benzonitrilek, eljárás előállításukra, és eljárás benzatiadiazol-7-karboxilsav előállítására
ATE327219T1 (de) Verfahren zur herstellung von hydroxymethylthiobuttersäure
ATE41154T1 (de) Verfahren zur herstellung alkanphosphoniger saeuren.
ATE187711T1 (de) Verfahren zur reinigung von o-phthaldialdehyd
ATE119154T1 (de) Verfahren zur herstellung von 2-chlor-5- chlormethyl-pyridin.
DE69430077D1 (de) Verfahren zur Herstellung von Zwischenprodukten, die für die Herstellung von Retroviral-Protease hemmenden Verbindungen verwendbar sind
ATE139765T1 (de) Verfahren zur herstellung von halogenanthranilsäuren
ATE207908T1 (de) Verfahren zur herstellung von 2-alkoxy-6- (trifluormethyl)-pyrimidin-4-ol
DE69532576D1 (de) Verfahren zur herstellung von 2-(tetrazol-5-yl)-4-oxo-4h-benzopyranen
DE69814771D1 (de) Gamma-oxohomophenylalanin derivate und ein verfahren zur herstellung von homophenylalanin derivaten durch reduktion derselben
ATE236909T1 (de) Verfahren zur herstellung von phosphorohalidaten
DE60028998T8 (de) Verfahren zur herstellung einer benzylamin-verbindung
ATE163181T1 (de) Verfahren zur herstellung von 2- cyaniminothiazolidin
ATE244228T1 (de) Verfahren zur herstellung von chloroacetylaminothiazoleaceticsäure derivate
DE59502722D1 (de) Verfahren und Zwischenprodukte zur Herstellung von 5-Oxaspiro [2.4] heptan-6-on
DE59806469D1 (de) Verfahren zur herstellung von 3-hydroxy-2-methylbenzoesäure
DE69718450D1 (de) Einfaches verfahren zur herstellung von hochwertigem captropril
DE69720432D1 (de) Verfahren zur herstellung von 2-hydroxynaphtalin-3,6-dicarbonsaure
ATE147064T1 (de) Verfahren zur herstellung von endo/exo-8-n,n- dialkylaminoexo-tricyclo(5.2.1.0 2,6) decan
ATE253553T1 (de) Verfahren zur herstellung von 2- alkylthiobenzonitril-derivaten
DE50213141D1 (de) Verfahren zur Herstellung von Glycinderivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification